Jill Knera

11 timestamped statements across 1 collection — auto-found in recorded discussions, each timestamp jumps to the exact moment.

Wilms Tumor · episode host

Featured diaries

▶ Ep 20 · 0:32
Factors that are being added are loss of heterozygosity of 11P15C, 1Q gain. And lymph node involvement.
quote · Wilms Tumor
▶ Ep 20 · 0:00
Risk stratification for Wilm's tumor has evolved many times over the years, so let's catch up.
quote · Wilms Tumor

Nothing matches these filters — clear the search or widen the filters.

Wilms Tumor 11 entries

Updated Favorable histology Wilms tumor risk stratification: Rationale for future Children’s Oncology Group clinical trials

▶ Ep 20 · 0:00
clinical Risk stratification for Wilms tumor has evolved many times over the years. ↗
▶ Ep 20 · 0:00
quote Risk stratification for Wilm's tumor has evolved many times over the years, so let's catch up. ↗
▶ Ep 20 · 0:09
guideline The Children's Oncology Group published updated risk stratification for patients with favorable histology Wilms tumor in Nature in June 2025. ↗
▶ Ep 20 · 0:19
guideline The new risk stratification model includes biological and clinical features that were not in the first generation risk stratification. ↗
▶ Ep 20 · 0:27
guideline The new model changes some of the older features or gets rid of them altogether. ↗
▶ Ep 20 · 0:32
quote Factors that are being added are loss of heterozygosity of 11P15C, 1Q gain. And lymph node involvement. ↗
▶ Ep 20 · 0:32
guideline Factors being added are loss of heterozygosity of 11P15, 1Q gain, and lymph node involvement. ↗
▶ Ep 20 · 0:41
quote Tumor nephrectomy weight is no longer included. ↗
▶ Ep 20 · 0:41
guideline Tumor nephrectomy weight is no longer included in the risk stratification. ↗
▶ Ep 20 · 0:43
guideline The model modified how histology and age are used to stratify certain patients. ↗
▶ Ep 20 · 0:48
opinion More changes are expected in the future as ongoing COG trials produce more results. ↗